IGHE and peanut allergic reaction: To address this issue, we have designed a unique in vitro system to mimic the effector phase of peanut allergy using novel, naturally occurring, peanut-specific human IgE monoclonal antibodies (mAbs) created via human hybridoma techniques (18) for sensitization of an established effector cell line.